155 related articles for article (PubMed ID: 38636144)
1. Predictors of genetic diagnosis in individuals with developmental and epileptic encephalopathies.
Luiza Benevides M; de Moraes HT; Granados DMM; Bonadia LC; Sauma L; Augusta Montenegro M; Guerreiro MM; Lopes-Cendes Í; Carolina Coan A
Epilepsy Behav; 2024 Jun; 155():109762. PubMed ID: 38636144
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of developmental and epileptic encephalopathies.
Van Bogaert P
Rev Neurol (Paris); 2022 Sep; 178(7):659-665. PubMed ID: 35489823
[TBL] [Abstract][Full Text] [Related]
3. Adult motor phenotype differentiates Dravet syndrome from Lennox-Gastaut syndrome and links SCN1A to early onset parkinsonian features.
Aljaafari D; Fasano A; Nascimento FA; Lang AE; Andrade DM
Epilepsia; 2017 Mar; 58(3):e44-e48. PubMed ID: 28186331
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation and diagnosis of severe epilepsy syndromes of early childhood.
Zupanc ML
J Child Neurol; 2009 Aug; 24(8 Suppl):6S-14S. PubMed ID: 19666878
[TBL] [Abstract][Full Text] [Related]
5. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies.
Zhou P; He N; Zhang JW; Lin ZJ; Wang J; Yan LM; Meng H; Tang B; Li BM; Liu XR; Shi YW; Zhai QX; Yi YH; Liao WP
Genes Brain Behav; 2018 Nov; 17(8):e12456. PubMed ID: 29314583
[TBL] [Abstract][Full Text] [Related]
6. Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.
Li W; Schneider AL; Scheffer IE
Epilepsia; 2021 Sep; 62(9):2205-2217. PubMed ID: 34338318
[TBL] [Abstract][Full Text] [Related]
7. The Expanding Clinical Spectrum of Genetic Pediatric Epileptic Encephalopathies.
Shbarou R; Mikati MA
Semin Pediatr Neurol; 2016 May; 23(2):134-42. PubMed ID: 27544470
[TBL] [Abstract][Full Text] [Related]
8. Epileptic encephalopathies: new genes and new pathways.
Nieh SE; Sherr EH
Neurotherapeutics; 2014 Oct; 11(4):796-806. PubMed ID: 25266964
[TBL] [Abstract][Full Text] [Related]
9. Myoclonic-astatic epilepsy of early childhood--clinical and EEG analysis of myoclonic-astatic seizures, and discussions on the nosology of the syndrome.
Oguni H; Fukuyama Y; Tanaka T; Hayashi K; Funatsuka M; Sakauchi M; Shirakawa S; Osawa M
Brain Dev; 2001 Nov; 23(7):757-64. PubMed ID: 11701290
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and comorbidities of SCN1A-related seizure disorders.
de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Sinoo C; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
Epilepsy Behav; 2019 Jan; 90():252-259. PubMed ID: 30527252
[TBL] [Abstract][Full Text] [Related]
11. Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy.
Nabbout R; Chemaly N; Chipaux M; Barcia G; Bouis C; Dubouch C; Leunen D; Jambaqué I; Dulac O; Dellatolas G; Chiron C
Orphanet J Rare Dis; 2013 Nov; 8():176. PubMed ID: 24225340
[TBL] [Abstract][Full Text] [Related]
12. Late infantile epileptic encephalopathy: A distinct developmental and epileptic encephalopathy syndrome.
Kacker S; Phitsanuwong C; Oetomo A; Nordli DR
Epileptic Disord; 2024 Feb; 26(1):98-108. PubMed ID: 38100275
[TBL] [Abstract][Full Text] [Related]
13. Genetic Diagnosis of Dravet Syndrome Using Next Generation Sequencing-Based Epilepsy Gene Panel Testing.
Lee J; Lee C; Park WY; Lee J
Ann Clin Lab Sci; 2020 Sep; 50(5):625-637. PubMed ID: 33067208
[TBL] [Abstract][Full Text] [Related]
14. Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies.
Mei D; Cetica V; Marini C; Guerrini R
Epilepsia; 2019 Dec; 60 Suppl 3():S2-S7. PubMed ID: 31904125
[TBL] [Abstract][Full Text] [Related]
15. CHD2 mutations are a rare cause of generalized epilepsy with myoclonic-atonic seizures.
Trivisano M; Striano P; Sartorelli J; Giordano L; Traverso M; Accorsi P; Cappelletti S; Claps DJ; Vigevano F; Zara F; Specchio N
Epilepsy Behav; 2015 Oct; 51():53-6. PubMed ID: 26262932
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic factors predicting Dravet syndrome in infants with
Cetica V; Chiari S; Mei D; Parrini E; Grisotto L; Marini C; Pucatti D; Ferrari A; Sicca F; Specchio N; Trivisano M; Battaglia D; Contaldo I; Zamponi N; Petrelli C; Granata T; Ragona F; Avanzini G; Guerrini R
Neurology; 2017 Mar; 88(11):1037-1044. PubMed ID: 28202706
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures.
Eschbach K; Moss A; Joshi C; Angione K; Smith G; Dempsey A; Juarez-Colunga E; Demarest ST
Epilepsy Res; 2018 Nov; 147():95-101. PubMed ID: 30286391
[TBL] [Abstract][Full Text] [Related]
18. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children.
Poke G; Stanley J; Scheffer IE; Sadleir LG
Neurology; 2023 Mar; 100(13):e1363-e1375. PubMed ID: 36581463
[TBL] [Abstract][Full Text] [Related]
20. Core Features Differentiate Dravet Syndrome from Febrile Seizures.
Nordli DR; Nordli DR; Galan FN
J Pediatr; 2023 Jul; 258():113416. PubMed ID: 37030608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
